JILLIAN SWAIN: Open Payments
NPI 1528840113 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 18 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $235 |
| ABBVIE INC. | 4 | $95 |
| UCB, Inc. | 3 | $66 |
| Amgen Inc. | 2 | $44 |
| PFIZER INC. | 2 | $43 |
| ANI Pharmaceuticals, Inc. | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Products named: RINVOQ, AIRSUPRA, Bimzelx, OTEZLA, XELJANZ, PURIFIED CORTROPHIN GEL, SAPHNELO.
Industry payments across AR — which companies pay providers there.
